A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy (Q35983156)

11 August 2017

A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy (English)

1 reference

11 August 2017

Wilson JK

1

1 reference

11 August 2017

Sargent JM

2

1 reference

11 August 2017

Elgie AW

3

1 reference

11 August 2017

Hill JG

4

1 reference

11 August 2017

Taylor CG

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 August 1990

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

62

1 reference

11 August 2017

2

1 reference

11 August 2017

189-194

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1990.258

11 August 2017

0 references

cites work

Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Improved optical detection of colony enlargement and drug cytotoxicity in primary soft agar cultures of human solid tumour cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Clonogenic and nonclonogenic in vitro chemosensitivity assays

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

In vitro screening of new drugs and analogues--specificity and selectivity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

The Princess Margaret Hospital study of ovarian cancer: stages I, II, and asymptomatic III presentations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Further observations on the effects of cancer chemotherapeutic agents on the in vitro dehydrogenase activity of cancer tissue.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Ovarian trials at the Royal Marsden.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971830

In vitro chemotherapy testing of gynecologic tumors: basis for planning therapy?

24 September 2018

1 reference

12 December 2020

A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma

1 reference

12 December 2020

[Anticancer drug sensitivity test using the short-term microplate culture and MTT dye reduction assay]

1 reference

12 December 2020

Long-term comparison of results of a drug sensitivity assay in vitro with patient response in lymphatic neoplasms

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.258

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

2386733

1 reference